Solid biosciences to present at the 43rd annual j.p. morgan healthcare conference

Charlestown, mass., jan. 08, 2025 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company” or “solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that bo cumbo, president and ceo, will present at the 43rd annual j.p. morgan healthcare conference on wednesday, january 15, 2025, at 3:45 p.m. pt (6:45 p.m. et).
SLDB Ratings Summary
SLDB Quant Ranking